Patent ID: 11858896
Assignee: CAAMTECH, INC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC C

Claim 1:
2. Crystalline N-methyl-N-allyl-tryptamine (MALT) hydrofumarate characterized by at least one of:
an orthorhombic, P21212; crystal system space group at a temperature of about 297 K;
unit cell dimensions a=7.9845 (7)Å, b=8.5641(6)Å, c=25.649 (2)Å, α=90°, β=90′, and y=90° at a temperature of about 297 K;
an x-ray powder diffraction (XRPD) pattern substantially similar to FIG. 8;
an x-ray powder diffraction (XRPD) pattern having at least two peaks selected from peaks 11.6, 13.0, 13.8, 16.6 and 18.3°2θ±0.2°2θ; and
an x-ray powder diffraction (XRPD) pattern having at least three peaks selected from peaks 11.6, 13.0, 13.8, 16.6 and 18.3°2θ±0.2°2θ.